aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

aTYR PHARMA (ATYR) reported Return on Capital Employed [ROCE] of -100.81% for Q2 2026, down 17.28 percentage points from -83.53% a year earlier and down 2.61 percentage points from the prior quarter.

Analysis

aTYR PHARMA (ATYR) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, aTYR PHARMA posted Return on Capital Employed [ROCE] of -97.32%, down 24.89 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for four consecutive years, with a five-year change of -46.95 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -72.42% in FY2024 (-12.60 pp), -59.82% in FY2023 (-9.27 pp), -50.55% in FY2022 (-2.72 pp) and -47.83% in FY2021 (+2.53 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2015.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last ten quarters, with an average year-over-year change of -20.68 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2022 (a gain of 21.07 percentage points); the low point was Q3 2024 (a drop of 39.95 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -98.21% (Q1 2026), -91.67% (Q4 2025) and -88.96% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 17.92%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.28%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 16.76%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.86%
10 aTYR PHARMA 16.67 Mn -276.34 Mn - -100.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -100.81%
Mar 31, 2026 -98.21%
Dec 31, 2025 -91.67%
Sep 30, 2025 -88.96%
Jun 30, 2025 -83.53%
Mar 31, 2025 -77.65%
Dec 31, 2024 -85.69%
Sep 30, 2024 -80.38%
Jun 30, 2024 -63.96%
Mar 31, 2024 -58.20%
Dec 31, 2023 -51.59%
Sep 30, 2023 -40.43%
Jun 30, 2023 -39.03%
Mar 31, 2023 -45.60%
Dec 31, 2022 -56.55%
Sep 30, 2022 -55.52%
Jun 30, 2022 -45.35%
Mar 31, 2022 -37.72%
Dec 31, 2021 -29.91%
Sep 30, 2021 -37.60%
API Access

aTYR PHARMA Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ATYR&period=max&api_key=YOUR_API_KEY